Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1801 1
1807 1
1842 1
1861 1
1865 3
1873 5
1877 3
1878 5
1879 2
1881 1
1883 1
1891 1
1894 3
1895 1
1896 1
1899 1
1903 1
1906 2
1908 2
1909 4
1911 1
1912 1
1913 2
1914 4
1915 1
1917 1
1918 3
1920 1
1921 2
1922 3
1923 1
1924 5
1925 2
1926 1
1927 1
1928 1
1929 3
1930 5
1931 1
1932 4
1933 6
1934 4
1935 7
1936 3
1937 1
1938 2
1939 2
1941 1
1942 1
1943 1
1944 1
1945 25
1946 39
1947 42
1948 53
1949 41
1950 78
1951 122
1952 99
1953 93
1954 93
1955 115
1956 81
1957 92
1958 107
1959 110
1960 89
1961 121
1962 133
1963 247
1964 242
1965 213
1966 240
1967 269
1968 280
1969 306
1970 345
1971 336
1972 379
1973 373
1974 370
1975 387
1976 463
1977 386
1978 451
1979 524
1980 453
1981 464
1982 519
1983 555
1984 511
1985 554
1986 579
1987 556
1988 540
1989 651
1990 641
1991 515
1992 577
1993 527
1994 617
1995 597
1996 654
1997 613
1998 628
1999 652
2000 682
2001 635
2002 718
2003 889
2004 940
2005 1068
2006 1159
2007 1252
2008 1395
2009 1587
2010 1673
2011 1863
2012 2095
2013 2203
2014 2401
2015 2563
2016 2715
2017 2977
2018 3151
2019 3324
2020 3062
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

52,841 results
Results by year
Filters applied: . Clear all
Page 1
Psoriasis.
Boehncke WH, Schön MP. Boehncke WH, et al. Lancet. 2015 Sep 5;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7. Epub 2015 May 27. Lancet. 2015. PMID: 26025581 Review.
Psoriasis provides many challenges including high prevalence, chronicity, disfiguration, disability, and associated comorbidity. ...In this Seminar, we highlight the clinical diversity of psoriasis and associated comorbid diseases. We describe recent developments in
Psoriasis provides many challenges including high prevalence, chronicity, disfiguration, disability, and associated comorbidity. ...I
Psoriasis Pathogenesis and Treatment.
Rendon A, Schäkel K. Rendon A, et al. Int J Mol Sci. 2019 Mar 23;20(6):1475. doi: 10.3390/ijms20061475. Int J Mol Sci. 2019. PMID: 30909615 Free PMC article. Review.
Research on psoriasis pathogenesis has largely increased knowledge on skin biology in general. In the past 15 years, breakthroughs in the understanding of the pathogenesis of psoriasis have been translated into targeted and highly effective therapies providing funda …
Research on psoriasis pathogenesis has largely increased knowledge on skin biology in general. In the past 15 years, breakthroughs in …
Generalized pustular psoriasis: a review and update on treatment.
Hoegler KM, John AM, Handler MZ, Schwartz RA. Hoegler KM, et al. J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1645-1651. doi: 10.1111/jdv.14949. Epub 2018 Apr 11. J Eur Acad Dermatol Venereol. 2018. PMID: 29573491 Review.
Generalized pustular psoriasis (GPP) is a subtype of pustular psoriasis characterized by painful and occasionally disfiguring cutaneous manifestations with sepsis-like systemic symptoms. ...Other forms of pustular psoriasis include impetigo herpetiformis, pal …
Generalized pustular psoriasis (GPP) is a subtype of pustular psoriasis characterized by painful and occasionally disfiguring …
Pathogenesis and clinical features of psoriasis.
Griffiths CE, Barker JN. Griffiths CE, et al. Lancet. 2007 Jul 21;370(9583):263-271. doi: 10.1016/S0140-6736(07)61128-3. Lancet. 2007. PMID: 17658397 Review.
Psoriasis, a papulosquamous skin disease, was originally thought of as a disorder primarily of epidermal keratinocytes, but is now recognised as one of the commonest immune-mediated disorders. ...Moreover, at least nine chromosomal psoriasis susceptibility loci have
Psoriasis, a papulosquamous skin disease, was originally thought of as a disorder primarily of epidermal keratinocytes, but is now re
The skin in psoriasis: assessment and challenges.
Oji V, Luger TA. Oji V, et al. Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S14-9. Epub 2015 Oct 15. Clin Exp Rheumatol. 2015. PMID: 26472560 Review.
The coexistence of psoriasis arthritis (PsA) and psoriasis vulgaris in about 20% of patients with psoriasis leads to a need for rheumatologic-dermatologic team work. We summarise the role of dermatologists in assessment of the skin in psoriasis. Chroni …
The coexistence of psoriasis arthritis (PsA) and psoriasis vulgaris in about 20% of patients with psoriasis leads to a …
Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities.
Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM. Bronckers IM, et al. Paediatr Drugs. 2015 Oct;17(5):373-84. doi: 10.1007/s40272-015-0137-1. Paediatr Drugs. 2015. PMID: 26072040 Free PMC article. Review.
Psoriasis is a common chronic immune-mediated inflammatory skin disorder and begins in childhood in almost one-third of the cases. ...Nevertheless, diagnosis of psoriasis is primarily based on clinical features. Pediatric psoriasis can have a profound long-te
Psoriasis is a common chronic immune-mediated inflammatory skin disorder and begins in childhood in almost one-third of the cases. ..
Risk Factors for the Development of Psoriasis.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Kamiya K, et al. Int J Mol Sci. 2019 Sep 5;20(18):4347. doi: 10.3390/ijms20184347. Int J Mol Sci. 2019. PMID: 31491865 Free PMC article. Review.
Psoriasis is an immune-mediated genetic skin disease. The underlying pathomechanisms involve complex interaction between the innate and adaptive immune system. ...Recent studies suggest that the exacerbation of psoriasis can lead to systemic inflammation and cardiov
Psoriasis is an immune-mediated genetic skin disease. The underlying pathomechanisms involve complex interaction between the innate a
Update on the pathophysiology of psoriasis.
Hugh JM, Weinberg JM. Hugh JM, et al. Cutis. 2018 Nov;102(5S):6-12. Cutis. 2018. PMID: 30566550 Review.
Psoriasis is a genetically programmed pathologic interaction among skin cells, immunocytes, and numerous biologic signaling molecules that is triggered by environmental stimuli. ...Further study in the pathogenesis of psoriasis can help identify targets for future t
Psoriasis is a genetically programmed pathologic interaction among skin cells, immunocytes, and numerous biologic signaling molecules
Models in the Research Process of Psoriasis.
Bocheńska K, Smolińska E, Moskot M, Jakóbkiewicz-Banecka J, Gabig-Cimińska M. Bocheńska K, et al. Int J Mol Sci. 2017 Nov 24;18(12):2514. doi: 10.3390/ijms18122514. Int J Mol Sci. 2017. PMID: 29186769 Free PMC article. Review.
Insights into the mechanisms responsible for psoriasis have generated an increasing number of druggable targets and molecular drugs. The development of relevant in vitro and in vivo models of psoriasis is now a priority and an important step towards its cure. ...
Insights into the mechanisms responsible for psoriasis have generated an increasing number of druggable targets and molecular drugs. …
Psoriasis risk factors and triggers.
Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Lee EB, et al. Cutis. 2018 Nov;102(5S):18-20. Cutis. 2018. PMID: 30566552 Review.
Numerous factors contribute to the onset and exacerbation of psoriasis. Genetic risk factors include HLA-Cw6 and mutations in the caspase recruitment domain family member 14 gene, CARD14. ...It is important for clinicians to be aware of these risk factors and triggers beca …
Numerous factors contribute to the onset and exacerbation of psoriasis. Genetic risk factors include HLA-Cw6 and mutations in the cas …
52,841 results
Jump to page
Feedback